The Innovation

Our patented Nano-Technology electrolytic process enables production of Pure and Stable HClO (Hypoclorous Acid) in a liquid carrier where all the most important parameters are balanced and optimized in order to obtain one of the best formulation in termsof Efficacy and Safety so maximizing its disinfectant and tissue regenerating properties. Interactive link with film of the technology.

Healthcare Market Potential

HClO is produced by human immune system as protective agent against infectious pathogens, including bacteria, viruses, yeasts and some fungi and it is also one of the primary driver in any tissue regeneration, wound healing process.

Scientific Development Status

Effective and Safe use of HClO for any therapeutical application in humans is strictly dependent on PH, ORP and stability. Bio'n presents a very low PH (below 3), a very high ORP (higher than 1'100 mv) and a good stability for 24 month. Bio'n is under investigation in the following target area: eye injuries , eye infection, chronic and acute infected wounds and acne but other applications of the product are possible. The first tests on the Product showed much promising results.